FRI0037 MER-MEDIATED EFFEROCYTOSIS TEMPERS ARTHRITIS BY PREVENTING NEUTROPHILS TO GO INTO SECONDARY NECROSIS AND SPILL THEIR INFLAMMATORY CONTENT IN THE JOINT
C.E.J. Waterborg, S. Beermann, M.B. Bennink, M.I. Koenders, P.L.E.M. van Lent, F. van den Hoogen, P.M. van der Kraan, F.A.J. van de Loo. Experimental Rheumatology, Radboudumc, Nijmegen, Netherlands Background: Rheumatoid arthritis is characterized by an inflammatory response in synovial joints, showing a predominant influx of neutrophils. These cells are cytotoxic and contribute to matrix degradation. In addition, they are implicated as a source of citrullinated auto-antigens, leading to the production of anti-citrullinated protein antibodies. Neutrophils have a relative short life span and many of them undergo apoptosis. If they are not cleared, they undergo secondary necrosis and release their cell content. A key mediator in the resolution of inflammation and the uptake of apoptotic cells, or efferocytosis, is the receptor tyrosine kinase Mer. Objectives: To elucidate the local role of Mer during gonarthritis. Methods: Macrophages were transduced by adenoviruses encoding the Mer ligand Pros1 or Luciferase. One day after the collagen booster injection in mice, Mer-specific antibodies or IgG antibodies, or adenoviruses overexpressing Pros1 or Luciferase were injected intravenously. Mice were euthanized at day 30 or 36, respectively. The KRN serum transfer arthritis model was induced by two intraperitoneal injections of arthritic K/BxN serum in either Mer-deficient or wild-type (WT) mice, or in mice that overexpress Pros1 or Luciferase in their knee joints. Mice were euthanized at day 7 or day 14, respectively. From all mice, serum was taken for cytokine profiling and knee joints were isolated for either synovial gene expression or histology and immunohistochemistry. Results: Adenoviral overexpression of the Mer ligand Pros1 resulted in reduced production of pro-inflammatory cytokines and chemokines by macrophages, compared to Luciferase. In addition, local Pros1 overexpression resulted in reduced expression of pro-inflammatory and pro-destructive mediators by synovial cells of arthritic mice. Systemic and local Pros1 overexpression diminished joint pathology, reduced the number of cleaved Caspase 3-positive apoptotic cells and secondary necrotic neutrophils. Conversely, inhibiting Mer-mediated efferocytosis by either Mer-specific antibodies or Mertk gene ablation resulted in aggravation of arthritis compared to controls, as evidenced by increased inflammation and tissue destruction. Additionally, Mer-inhibited mice had increased numbers of apoptotic cells in their knee joints, and higher serum levels of IL-16C, a cytokine released by secondary necrotic neutrophils.
Conclusions:
Together, these results demonstrate that Mer locally plays a unique protective role in knee joint disease by enhancing resolution of arthritis. Our data suggest that promoting and/or restoring Mer-mediated uptake of apoptotic cells in the arthritic joint might be therapeutically beneficial. Background: Extracellular citrullination catalyzed by peptidylarginine deiminase (PAD) is thought to play a central role in the pathogenesis of rheumatoid arthritis. Neutrophils are a major reservoir of PAD2 and PAD4. Cellular release of PAD2 and PAD4 is usually considered a consequence of cell death. Objectives: We aimed to determine if PAD2 can be released from live, activated neutrophils as an active process. Methods: Whole blood cells were purified from healthy blood were stimulated with phorbol 12-myristate 13-acetate (PMA). To capture PAD2 released from neutrophils and detect it by flow cytometry, we used biotinylated anti-CD15 and anti-PAD2 (mAb DN6) mAbs linked by streptavidin, and a different PE-labelled anti-PAD2 amtibody (mAb DN2). In addition, intracellular PAD2 was quantified by intracellular staining with PE-anti-PAD2. PAD2 released from leukocytes and subcellular fractions of human granulocytes were assessed for content of PAD2 using an in-house luminex-based assay. Results: On incubation of whole blood cells with PMA, PAD2 was detectable in the supernatants after 30 minutes, and levels increased thereafter in parallel with increasing cell death. However, using PAD2 catch reagent, we found that live neutrophils released PAD2 in the 30 minutes after stimulation. Intracellular staining for PAD2 showed that the content of PAD2 in live neutrophils decreased correspondingly. Upon subcellular fractioning of granulocytes, the majority of PAD2 was found in cytosol and, in 25 times lower quantities, in the fraction containing plasma membranes and secretory vesicles. Sparse amounts of PAD2 were also observed in gelatinase granules.
In conclusion, PAD2 can be released from live, activated neutrophils, which may contribute to extracellular citrullination and thereby play a role in driving inflammatory processes in RA patients with immune responses to citrullinated proteins. Objectives: The aim of this study was to determine the effect of MTX on endothelial function in arthritis and to investigate its effect on endothelial pathways. Methods: Experiments were conducted in the adjuvant-induced arthritis (AIA) model in Lewis rat. At onset of arthritis, rats were treated by a sub-cutaneous injection of MTX (1 mg/kg/week) or phosphate buffer saline (vehicle) for 3 weeks. Arthritis score was daily monitored. At the end of treatment, thoracic aorta was harvested to measure the relaxation to acetylcholine on pre-constricted aortic rings in the presence or not of inhibitor of nitric oxide (NO) synthase (L-NAME), arginase (nor-NOHA), EDHF (Apamin/Charybdotoxin), or a superoxide dismutase analog (Tempol). The effect of norepinephrine (NE) and sodium nitroprusside
